Max G. Bronstein is the Assistant Director for Health Innovation in the White House Office of Science & Technology Policy (OSTP). At OSTP, Max is helping to lead efforts in launching Advanced Research Projects Agency for Health (ARPA-H), broadening access to clinical sequencing, and reconceptualizing drug development models for areas of high unmet medical need. Previously, he ran a boutique consulting firm, serving clients in the biotechnology and non-profit sectors. While in the private sector, Max was the Senior Director of Health Policy & Corporate Affairs at Audentes Therapeutics, leading company interactions with state and federal policymakers, while driving various coalitions to advance patient-focused policies for gene therapy and regenerative medicine. In particular, Max was a leader of efforts to promote payment model innovation for gene therapy products as well as ensure the strongest possible standards in the US for diagnosis of rare diseases. Previously, Max was the Chief Advocacy & Science Policy Officer at the EveryLife Foundation for Rare Diseases where he led the Foundation’s policy initiatives to close the innovation gap for rare diseases and to enhance newborn screening in America. In 2016, the EveryLife Foundation successfully advocated for the passage of the 21st Century Cures Act and played a key role in advocating for newborn screening reform in California and Florida to help babies born with rare diseases. Max has also published in STAT, Pediatrics, Forbes, Nature, and the New England Journal of Medicine on topics like patient engagement in drug development and the importance of leveraging incentives for closing the innovation gap for rare diseases. He is the former Director of Science Policy at Research!America where he advocated for increased appropriations for critical health research agencies like the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). Max has held various positions in the U.S. government, including at the National Science Foundation, the U.S. House Committee on Science & Technology, and the National Institutes of Health. In 2010, Max founded a non-profit organization, the Journal of Science Policy & Governance, to empower students and young scholars to publish their work. He holds a master’s degree in public policy and a certificate in science and technology policy from the Ford School at the University of Michigan in addition to a BA in biology from Ithaca College, with a minor in writing. Max resides in the DC-area and is an avid sailor, swimmer, kayaker, and diver.